Properties
Description
Poloxin is an CDK kinase inhibitor that disrupts cell division processes. It targets PLK1 PBD, PLK2 PBD, and PLK3 PBD.
Molecular Formula
C18H19NO3
Targets
PLK1 PBD: 4.8 μM; PLK2 PBD: 18.7 μM; PLK3 PBD: 53.9 μM
Identity
Confirmed by NMR/HPLC/MS.
Applications
Poloxin can be used to investigate the inhibition of Polo-like kinase 1 (Plk1) and its effects on mitotic progression and cancer therapy.